Title:
LIGNOCELLULOSIC CONVERSION PROCESS WITH TISSUE SEPARATION
Document Type and Number:
WIPO Patent Application WO/2013/165962
Kind Code:
A3
Abstract:
Methods of producing renewable materials, such as biofuels, may include separating lignocellulosic feedstock into various fractions, pretreating at least one of the fractions, and further treating the pretreated fraction(s) to produce a renewable material. More particularly, an outer-most stalk tissue, or rind, of the lignocellulosic feedstock having the least-accessible carbohydrates can be separated from the leaves and pith of the feedstock. Then the easily-accessible leaves, pith, and sugars can be processed together, while the rind can either be processed separately to produce a renewable material, or turned into other products. In certain embodiments, a cane tissue fractionation system is included at a front end of a sugar mill.
Inventors:
BINDER JOSEPH B (US)
BORDEN JACOB (US)
CHAPPELL MICHAEL L (US)
BORDEN JACOB (US)
CHAPPELL MICHAEL L (US)
Application Number:
PCT/US2013/038783
Publication Date:
July 24, 2014
Filing Date:
April 30, 2013
Export Citation:
Assignee:
BP CORP NORTH AMERICA INC (US)
BINDER JOSEPH B (US)
BORDEN JACOB (US)
CHAPPELL MICHAEL L (US)
BINDER JOSEPH B (US)
BORDEN JACOB (US)
CHAPPELL MICHAEL L (US)
International Classes:
C12P7/10
Foreign References:
| US5730837A | 1998-03-24 | |||
| US4520105A | 1985-05-28 |
Other References:
JOSEPH B BINDER AND RONALD T RAINES: "Simple Chemical Transformation of Lignocellulosic Biomass into Furans for Fuels and Chemicals", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, ACS PUBLICATIONS, USA, vol. 131, 11 February 2009 (2009-02-11), Washington DC USA, pages 1979 - 1985, XP002542736, ISSN: 0002-7863, [retrieved on 20090121], DOI: 10.1021/JA808537J
Attorney, Agent or Firm:
POLIAK, John P. et al. (150 W. Warrenville RoadMail Code 200-1, Naperville Illinois, US)
Download PDF:
Previous Patent: A WATER-ACTIVATED, INGESTIBLE BATTERY
Next Patent: TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON
Next Patent: TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON